NeoStem trades up again today off its switch to NASDAQ; names new Chief Medical Officer

|By:, SA News Editor

NeoStem (NBS +6.7%) trades up again today after the cellular therapy company switched to the NASDAQ Stock Market from the NYSE yesterday.

Additionally, it's also named Dr. Douglas W. Losordo as its chief medical officer.

Dr. Losordo most recently was vice president of New Therapies Development, Regenerative Medicine and Baxter Ventures at Baxter International.